A study of ASP-0819 for the treatment of fibromyalgia.
Phase of Trial: Phase I
Latest Information Update: 03 Aug 2016
At a glance
- Drugs ASP 0819 (Primary)
- Indications Fibromyalgia
- Focus Adverse reactions
- 03 Aug 2016 New trial record
- 31 Jul 2015 According to an Astellas Pharma, the company plans to initiate this study in Oct 2015.